Dulera (Mometasone/Formoterol) for asthma | MyAsthmaTeam

Connect with others who understand.

sign up Log in
About MyAsthmaTeam
Powered By

Dulera is a prescription drug approved by the U.S. Food and Drug Administration (FDA) for maintenance treatment of asthma for people age 5 and older. Dulera is not indicated for rescue usage during acute bronchospasms.

Dulera is a combination drug containing both Mometasone and Formoterol. Mometasone is a glucocorticoid steroid, a drug that suppresses the immune system. Mometasone is believed to work by reducing inflammation in the lungs, lowering the risk of bronchospasm. Formoterol is a long-acting bronchodilator, a drug that dilates the bronchi and bronchioles in the lungs, making it easier to breathe. Formoterol is believed to work by relaxing smooth muscles in the airways.

How do I take it?
Dulera is inhaled orally twice a day.
Dulera comes in an aerosol inhaler.

Side effects
The FDA-approved label for Dulera lists common side effects including headache, runny nose, and sinus infection.

Rare but serious side effects listed for Dulera include worsening of asthma, heart issues, hypersensitivity reactions, increased risk of infections, and paradoxical bronchospasm (bronchospasm caused by taking medication).

For more details about this treatment, visit:
Dulera — Merck

Continue with Facebook
Continue with Google
Your privacy is our priority. By continuing, you accept our Terms of use and Privacy policy.
Already a Member? Log in